Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Review Article Volume 4 Issue 5

History, Symptoms and Preventive Measures of Coronavirus Disease-19 (COVID-19): Mini Review

Mohd Asif Khan1* and Deeksha Sahai2

1Assistant Professor, Future Institute of Pharmacy, Future University, Bareilly, UP, India
2Assistant Professor, BIU College of Pharmacy, Bareilly International University, Bareilly, UP, India

*Corresponding Author: Mohd Asif Khan, Assistant Professor, Future Institute of Pharmacy, Future University, Bareilly, UP, India.

Received: February 20, 2020; Published: April 17, 2020



  In 1968, term ‘coronavirus’ was first coined. It shows crown-like morphology when observed under electron microscope. CoVs are summarized into four genera such as Alphacoronavirus, Betacoronavirus, Gammacoronavirus and Deltacoronavirus. Betacoronavirus was further classified into four lineages A, B, C and D. Total 06 species of human coronaviruses have been discovered including OC43, 229E, NL63, HKU1, SARS-CoV and MERS-CoV. A novel (new) coronavirus is recently discovered in December 2019 in Wuhan city of China. The coronavirus belongs to family- Coronaviridae; largest family in Nidovirales order. Chinese authority declared it as a novel coronavirus (nCoV-19). MERS-CoV was detected in camel serum- being almost identical to human coronaviruses. Bats have been a natural reservoir of coronaviruses lineages and thought as ancestor for all coronavirus lineages. In India, 9 deaths have been reported till 24 March 2020. The Print reports that with current rate India can see 30000 COVID-19 deaths by May, as no hospital bed by June. It concludes that its clinical signs and symptoms are almost similar to pneumonia. It indicates to researchers to work on genetic configuration (genome) of coronavirus to develop more specific vaccine to save life of society and world.

Keywords:nCoV-19 (COVID-19); SARS-CoV; MERS-CoV; Bat; Transmission



Citation: Mohd Asif Khan and Deeksha Sahai. “History, Symptoms and Preventive Measures of Coronavirus Disease-19 (COVID-19): Mini Review" Acta Scientific Pharmaceutical Sciences 4.5 (2020): 25-26.


Acceptance rate32%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US